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Acute kidney injury, a common complication of cardiac
surgery with cardiopulmonary bypass, is associated with
increased morbidity and mortality. Ischemic preconditioning
at a remote site mitigates ischemia–reperfusion injury and
may prevent acute kidney injury after cardiac surgery, thus
providing clinical benefit. To further study this, we enrolled
120 adult patients undergoing elective cardiac surgery
for whom cardiopulmonary bypass was anticipated in
a randomized, single-blind, and controlled pilot trial.
Patients were stratified for the type of surgery and equally
assigned to a control group or to receive remote ischemic
preconditioning by an automated thigh tourniquet
consisting of three 5-min intervals of lower extremity
ischemia separated by 5-min intervals of reperfusion.
The primary end point was acute kidney injury defined as
an elevation of serum creatinine of X0.3mg/dl or X50%
within 48h after surgery. Fifty-nine patients in each group
were analyzed on an intention-to-treat basis. Acute kidney
injury occurred in 12 remote ischemic preconditioned and
28 control patients, reflecting an absolute risk reduction
of 0.27 and a significantly reduced relative risk due to
preconditioning of 0.43. Hence, remote ischemic
preconditioning prevents acute kidney injury in patients
undergoing cardiopulmonary bypass-assisted cardiac
surgery.
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Acute kidney injury, a significant complication of cardiac
surgery, is occurring with greater frequency as patients at
high risk for complications are increasingly referred for
surgery.1,2 Depending on how it is defined, acute kidney
injury occurs in up to 45% of patients after cardiac surgery,
and approximately 1 to 2% require renal replacement
therapy.3–5 Patients with acute kidney injury after cardiac
surgery are at risk for lengthened intensive care unit and
hospital stays and for short-term and long-term mortal-
ity.3,5–11 Recognizing that even small increases in serum
creatinine levels are associated with increased morbidity
and mortality, the Acute Kidney Injury Network (AKIN) has
recommended an acute increase in the serum creatinine
concentration of X0.3mg/dl as a diagnostic criterion for
acute kidney injury.12
Cardiopulmonary bypass is employed in most cardiac
surgeries, and although the mechanisms are not fully under-
stood, ensuing ischemic, inflammatory, and oxidative injuries
to renal tubular epithelial cells have been implicated in the
cause of acute kidney injury.13 Despite numerous clinical
trials of pharmacologic interventions, a means to prevent
acute kidney injury associated with cardiac surgery has
remained elusive.13–16
Remote ischemic preconditioning is a phenomenon in
which ischemia–reperfusion injury of an organ is mitigated
by previous application of brief ischemic intervals in a distant
organ or limb.17,18 Several encouraging trials of remote
ischemic preconditioning have suggested clinical benefit.19–25
Because the mechanisms of ischemia–reperfusion injury26,27
are similar to those proposed for acute kidney injury after
cardiopulmonary bypass, we tested the hypothesis that
remote ischemic preconditioning prevents acute kidney
injury in patients undergoing cardiac surgery.
RESULTS
Study patients
We randomized 120 patients to remote ischemic precondi-
tioning (n¼ 60) and control (n¼ 60) groups: 79 scheduled
for coronary artery bypass grafting (CABG), 18 for valve
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surgery, and 23 for combined CABG and valve or other
surgery (Figure 1). When scheduled and actual surgeries
were different, actual surgeries were used for the intention-
to-treat and per-protocol analyses. One CABG patient was
randomized from a block used out of sequence. After
exclusion of 2 patients (1 remote ischemic precondi-
tioning patient and 1 control patient for whom second
postoperative day serum creatinine levels were not obtained),
59 patients in each group were included in the intention-to-
treat analysis. Two patients who underwent CABG without
cardiopulmonary bypass were excluded in the per-protocol
analysis.
The remote ischemic preconditioning and control groups
were not significantly different with respect to baseline
characteristics (Table 1) and operative data (Table 2), except
that more patients in the control group had a history of
previous cardiac surgery. Prediction scores for acute kidney
injury requiring renal replacement therapy were similar
between groups, as were the proportions of patients at
moderate or high risk (score 42).
Primary outcome
Significantly fewer patients in the remote ischemic pre-
conditioning group had acute kidney injury within 48 h
after surgery compared with the control group (20% vs
47%; P¼ 0.004; relative risk, 0.43; 95% confidence interval
(CI), 0.24–0.76; absolute risk reduction, 0.27; 95% CI,
0.10–0.42) (Table 3). Per-protocol analysis confirmed this
result (21% vs 48%; P¼ 0.003; relative risk, 0.43; 95% CI,
0.24–0.76).
Because significantly more patients in the control group
than in the intervention group had a history of previous
cardiac surgery, we performed an additional w2 analysis
stratified on previous cardiac surgery history, with nearly
identical results (relative risk, 0.45; P¼ 0.004).
Secondary outcomes
Median change in plasma neutrophil gelatinase-associated
lipocalin (NGAL) levels, drawn immediately before the
preconditioning regimen and 3 h after cardiopulmonary
bypass, did not differ significantly between the remote
ischemic preconditioning and control groups (39 vs 43 ng/ml,
respectively; P¼ 0.46). We observed a nonsignificant differ-
ence in the incidence of postoperative oliguria during the
initial 12 h after surgery between remote ischemic precondi-
tioning and control groups (7% vs 2%, respectively; P¼ 0.36;
Table 3). Per-protocol analysis remained nonsignificant for
both outcomes (data not shown).
Other renal outcomes
In a post hoc analysis of patients who had acute kidney injury,
11 (19%) and 23 (39%) patients had stage I acute kidney
injury, and 1 (2%) and 5 (8%) patients had stage II acute
kidney injury in the remote ischemic preconditioning and
control groups, respectively (P¼ 0.005; Table 3). No patients
had stage III acute kidney injury within the first post-
operative 48 h or required renal replacement therapy before
hospital discharge.
Significantly fewer patients in the remote ischemic
preconditioning group had sustained acute kidney injury
for at least 2 consecutive days compared with the control
group (17% vs 36%; P¼ 0.04). Sustained acute kidney injury
for at least 3 consecutive days occurred less frequently in the
remote ischemic preconditioning group (8% vs 19%), but
this difference was not statistically significant (P¼ 0.18;
Table 3).
Other postoperative outcomes and adverse events
We found no significant differences between groups in
the use of vasoactive drugs, prolonged mechanical venti-
lation, or need for reintubation. No patients had post-
operative myocardial infarction. One patient in the remote
ischemic preconditioning group had postoperative con-
gestive heart failure. Length of intensive care unit stay
and hospital stay after surgery were comparable. One
patient in the control group died 2 days after surgery
(Table 3).
120 Patients enrolled and stratified
Actual surgery: Actual surgery:
59 Included in ITT analysis59 Included in ITT analysis
58 Included in PP analysis 58 Included in PP analysis
1 CABG surgery done off-pump
1 ASD closure missing one
< 48-h creatinine
1 CABG surgery done off-pump
1 Valve surgery missing one
< 48-h creatinine
79 CABG
18 Valve
23 Combined or other
41 CABG
8 Valve
11 Combined or other
42 CABG
9 Valve
9 Combined or other
38 CABG
8 Valve
14 Combined or other
42 CABG
9 Valve
8 Combined or other
38 CABG
7 Valve
14 Combined or other
37 CABG
7 Valve
14 Combined or other
41 CABG
9 Valve
8 Combined or other
38 CABG
10 Valve
12 Combined or other
60 Randomized to RIPC
  Scheduled surgery:
60 Randomized to control
Scheduled surgery:
Figure 1 |Patient flowchart. Enrolled patients are stratified by
scheduled surgery and randomized to study groups. The coronary
artery bypass grafting (CABG) patients operated off-pump
were included in the intention-to-treat (ITT) analysis. ASD, atrial
septal defect; PP, per-protocol; RIPC, remote ischemic
preconditioning.
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DISCUSSION
Our study shows that remote ischemic preconditioning
prevents acute kidney injury in patients undergoing cardiac
surgery with cardiopulmonary bypass. We observed a 27%
absolute risk reduction in the primary end point of an acute
increase in serum creatinine levels by at least 0.3mg/dl or
50% more than the baseline value within 48 h of surgery.
Sustained acute kidney injury in which serum creatinine
levels remained elevated for at least 2 consecutive days was
also significantly reduced in the remote ischemic precondi-
tioning group.
Several studies have described an association between
acute kidney injury and increased morbidity, short-term and
long-term mortality, and use of resources in various patient
populations.3,5–11,28–30 These relationships hold true even
with small increases of serum creatinine levels for hospital
inpatients and patients who have undergone cardiac
surgery.5,7–9,28,30 Moreover, the associations persist after
adjustment for comorbidities and other factors predisposing
to acute kidney injury, suggesting that even mild and
clinically transient acute kidney injury has lasting effects on
patient survival rather than simply being a marker for
comorbidities and other contributors to mortality. Establish-
ment of a method to prevent acute kidney injury in at-risk
patients could substantially improve health outcomes.
Remote ischemic preconditioning has shown promise
in randomized, controlled trials as a means for myocardial
protection during coronary bypass surgery,20,23 surgical
repair of congenital heart defects,19 and before percutaneous
coronary interventions.22,24 Two studies have reported a
protective effect of remote ischemic preconditioning on renal
function. In a randomized, controlled trial, Ali et al.21
observed a relative risk for postoperative ‘renal impairment’
(that is, serum creatinine level 42.0mg/dl) of 0.25 in
patients who had undergone abdominal aortic aneurysm
repair and received preconditioning before surgery. Venugopal
et al.25 retrospectively analyzed two randomized controlled
Table 1 | Baseline characteristics of the study patients according to intervention group
RIPC (n=59) Control (n=59) P-value
Age, year 62±9a 65±11 0.14
Male sex, no. (%) 41 (69) 40 (68) 0.84
Preoperative creatinine, mg/dlb 0.93±0.24 0.95±0.31 0.68
GFR o60ml/min per 1.73m2, no. (%)c 10 (17) 9 (15) 0.80
Comorbidities
Hypertension, no. (%) 44 (75) 50 (85) 0.25
Diabetes mellitus 24 (41) 21 (36) 0.70
Insulin requiring, no. (%) 9 (15) 5 (8) 0.39
Congestive heart failure, no. (%) 10 (17) 9 (15) 0.80
Peripheral vascular disease, no. (%) 8 (14) 10 (17) 0.80
Chronic obstructive pulmonary disease, no. (%) 11 (19) 5 (8) 0.18
Previous heart surgery, no. (%) 6 (10) 15 (25) 0.05
Left ventricular ejection fraction o35%, no. (%) 8 (14) 4 (7) 0.36
Coronary angiogram p2 days before, no. (%) 18 (31) 15 (25) 0.68
Preoperative intraaortic balloon pump, no. (%) 3 (5) 1 (2) 0.62d
Preoperative medications
Sulfonylurea, no. (%) 6 (10) 3 (5) 0.49d
ACE-I or ARB, no. (%) 14 (24) 14 (24) —
NSAID or COX-2 inhibitor, no. (%) 2 (3) 0 (0) 0.50d
Acute kidney injury propensity score
Median (range) 2 (0, 5) 2 (0, 9) 0.77e
Score denoting moderate or high risk, no. (%) 16 (27) 20 (34) 0.55
Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; COX-2, cyclooxygenase 2; GFR, glomerular filtration rate; NSAID,
nonsteroidal anti-inflammatory drug; RIPC, remote ischemic preconditioning.
aThe ± values are means±s.d.
bTo convert values for creatinine to mmol/l, multiply by 88.4.
cGFR is calculated by a simplified Modification of Diet in Renal Disease (MDRD) formula.
dFisher’s exact test.
eMann–Whitney U test.
Table 2 | Operative characteristics of the patients according
to intervention group
RIPC (n=59) Control (n=59) P-value
CPB time, min 115±37a 113±37 0.84
Aortic cross-clamp time, min 73±38 68±35 0.54
Isoflurane anesthesia, no. (%) 59 (100) 59 (100) —
Type of surgery
CABG only, no. (%) 42 (71) 38 (64) 0.35
Valve only, no. (%) 9 (15) 7 (12)
Combined or other, no. (%) 8 (14) 14 (24)
Abbreviations: CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass;
RIPC, remote ischemic preconditioning.
aThe ± values are means±s.d.
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trials of remote ischemic preconditioning for myocardial
protection during coronary artery bypass graft surgery. The
relative risk for acute kidney injury, defined by AKIN criteria,
in patients who received the preconditioning regimen was
0.42, a finding of marginal statistical significance (P¼ 0.10). In
contrast to our findings and those of Ali et al.21 and Venugopal
et al.,25 a randomized controlled trial of remote ischemic
preconditioning in 162 patients undergoing coronary artery
bypass graft surgery while on cardiopulmonary bypass failed to
demonstrate renal protection with preconditioning.31 Post-
operative serum creatinine was not measured until the fourth
day following surgery. A protective effect of remote ischemic
preconditioning on renal function may therefore have gone
undetected if a significant number of subjects had acute kidney
injury that began to resolve within the first 4 days after
surgery.
How remote ischemic preconditioning protects against
ischemia–reperfusion injury is uncertain. Evidence exists for
neural and humoral mediators of signal transduction
between the preconditioning stimulus and target organ.
The most downstream events appear to be the same as for
local preconditioning: preservation of mitochondrial func-
tion by opening of mitochondrial or plasmalemmal adeno-
sine-50-triphosphate (ATP)-sensitive potassium channels and
closure of the mitochondrial permeability transition pore.32
Sulfonylurea medications, which inhibit ATP-sensitive po-
tassium channel conductance, may impede the effects of
remote ischemic preconditioning.33 We chose not to exclude
from our study diabetic patients taking sulfonylureas to keep
the study relevant to current clinical practice. Of the study
patients, o10% took sulfonylureas within 48 h of their
surgery. Although isoflurane might have had a precondition-
ing influence,34,35 we chose not to modify the anesthetic
regimen to maintain the clinical relevance of the study.
Although an increase in serum creatinine levels remains
the standard by which acute kidney injury is defined, the
sensitivity of serum creatinine values to so-called prerenal
states is a significant shortcoming, particularly after cardiac
surgery, when patients often exhibit significant cardiovascu-
lar instability. NGAL, which is heavily expressed in the kidney
shortly after ischemic injury, appears not to be sensitive to
hemodynamic changes and has been studied as a plasma
biomarker for acute kidney injury in pediatric and adult
cardiac surgery patients.4,36–40 Our finding of no difference
between groups in changes of plasma NGAL levels is of
uncertain significance. Three small studies report conflicting
data on the performance of plasma NGAL values during the
first 6 h after cardiac surgery in adults and show that urinary
NGAL levels provide a better marker of acute kidney
injury.4,36,37
This study has certain limitations. Rather than reflecting
attenuation of acute kidney injury in the preconditioning
group, the observed difference in the primary outcome may
indicate the protective effect of remote ischemic precondi-
tioning on ischemic myocardium and, consequently, pre-
served renal plasma flow and glomerular filtration. The
comparable use of vasoactive medications between groups
in the initial 48 h after surgery, however, suggests that this
is not the case. Studies showing associations between acute
kidney injury not requiring renal replacement therapy and
adverse clinical outcomes have used serum creatinine
concentrations to identify episodes of acute kidney injury
and have not differentiated prerenal conditions from true
kidney injury.5–10,28–30 Acute increases in serum creatinine
levels because of hemodynamic effects may therefore predict
poor outcomes.
Another limitation of this study is that our definition
of acute kidney injury for the primary end point, and the
AKIN criteria from which it was derived, do not take into
consideration the duration of elevation in serum creatinine.
Although even transient elevations in serum creatinine
predict adverse outcomes,41 a retrospective study of patients
who underwent cardiac surgery found that duration of
postoperative acute kidney injury was directly proportional
Table 3 | Postoperative outcomes according to intervention
group
RIPC
(n=59)
Control
(n=59) P-value
Primary outcome
AKI, no. (%) 12 (20) 28 (47) 0.004
Secondary outcomesa
Change in plasma NGAL, ng/mlb 39 (58, 284) 43 (47, 203) 0.46c
Oliguria, no. (%) 4 (7) 1 (2) 0.36d
Other renal outcomes
Sustained AKI
X2 days, no. (%) 10 (17) 21 (36) 0.04
X3 days, no. (%) 5 (8) 11 (19) 0.18
AKI by AKIN stage
No AKI, no. (%) 47 (80) 31 (53) 0.005d
Stage I, no. (%) 11 (19) 23 (39)
Stage II, no. (%) 1 (2) 5 (8)
Stage III, no. (%) 0 (0) 0 (0)
RRT, no. (%) 0 (0) 0 (0) —
Interventions
Vasoactive drugs, 0–48 h, no. (%) 48 (81) 43 (73) 0.38
Vasoactive drugs at 48 h, no. (%) 22 (37) 20 (34) 0.85
MV 448 h, no. (%) 3 (5) 4 (7) 40.99d
Reintubation, no. (%) 2 (3) 2 (3) —
Complications
Myocardial infarction 0 (0) 0 (0) —
Congestive heart failure 1 (2) 0 (0) 40.99d
Hospital outcomes
ICU stay 43 days, no. (%) 12 (20) 8 (14) 0.46
Hospital stay after surgery, daysb 7 (3, 35) 6 (4, 49) 0.39c
Hospital death, no. (%) 0 (0) 1 (2) 40.99d
Abbreviations: AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; ICU,
intensive care unit; MV, mechanical ventilation; NGAL, neutrophil gelatinase-
associated lipocalin, RIFLE, risk, injury, failure, loss, and end-stage disease; RIPC,
remote ischemic preconditioning; RRT, renal replacement therapy.
aNGAL data were analyzed for 53 RIPC patients and 55 control patients. Oliguria data
were analyzed for 56 RIPC patients and 57 control patients.
bReported as median (range).
cMann–Whitney U test.
dFisher’s exact test.
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to long-term mortality.42 We therefore assessed for differ-
ences between study groups in sustained acute kidney injury.
Although the available data were limited (see Materials and
Methods and Supplementary Tables S1 and S2 online), we
found a lower incidence of sustained acute kidney injury in
the remote ischemic preconditioning group.
Because the urinary catheters of many patients are
removed within the first day after surgery at our institution,
rather than employing the full AKIN definition of acute
kidney injury for the primary outcome, we chose to include
the criterion for urine output as a secondary outcome for the
initial postoperative 12 h. Whether oliguria is an independent
marker for acute kidney injury remains in doubt,12 and we
consider this a minor limitation.
Only patients and those performing creatinine and NGAL
assays were blinded to randomization. It was impracticable to
keep surgical and anesthesiologic staff unaware of group
assignment without undue disruption of standard clinical
care in the operating room. Care providers’ awareness of
study group assignment, therefore, could have influenced
intraoperative and postoperative care and affected the
outcomes of interest for this study. Although we observed
comparable use of vasoactive medications in the post-
operative period, we did not compare volumes of adminis-
tered intravenous fluids between groups, a potential source
of bias.
Our study protocol allowed for assessment of acute kidney
injury only when its onset was within the first 48 h after
surgery. We might have observed more acute kidney injury
had we measured serum creatinine beyond 48 h for all
patients, but we consider this a minor shortcoming as it is
unlikely to have biased the results in favor of either group.
There was a notable imbalance between study groups for
previous heart surgery, a known risk factor for acute kidney
injury after heart surgery,13,43 favoring the remote ischemic
preconditioning group. Nevertheless, propensity scores were
not significantly different because of small imbalances in
insulin-requiring diabetes mellitus, chronic obstructive
pulmonary disease, and low left ventricular ejection fraction
favoring the control group. Finally, the observed effect of
remote ischemic preconditioning on the incidence of acute
kidney injury in our study was rather large, yet it was
consistent with the results of the studies of Ali et al.21 and
Venugopal et al.,25 providing some reassurance that our
findings approximate the true effect size for our study
population.
Although acute kidney injury is associated with poor
outcomes, it remains to be seen whether preventing acute
kidney injury in any setting will reduce morbidity, mortality,
and utilization of resources. A larger, multicenter study of
remote ischemic preconditioning powered for these end
points is warranted.
In conclusion, our study shows that remote ischemic
preconditioning prevents acute kidney injury after cardiac
surgery with cardiopulmonary bypass. Larger trials are
necessary to determine whether this will translate into
improvement in morbidity, mortality, and utilization of
resources.
MATERIALS AND METHODS
Study patients
Between November 2008 and October 2009, patients who were
scheduled to undergo elective cardiac surgery at Maine Medical
Center and for whom cardiopulmonary bypass was anticipated
were considered for enrollment. Exclusion criteria included age
480 years or o18 years, known peripheral vascular disease of the
lower extremities associated with active skin necrosis or infection,
end-stage renal disease, planned off-pump surgery, or inability to
give informed consent. The study coordinator and two assistants
identified potential subjects from the operating room schedule,
enrolled consenting subjects, and assigned participants to study
groups. This study was conducted in accordance with the
Declaration of Helsinki Principles. The institutional review board
of Maine Medical Center approved the study, and all subjects gave
written informed consent before their participation. The study was
registered at clinicaltrials.gov (NIH identifier NCT00821522).
Study design
Patients were stratified by type of scheduled surgery (that is, CABG,
valvular surgery, combined CABG and valvular surgery, or other
cardiothoracic surgery requiring cardiopulmonary bypass), and they
were randomized within strata to remote ischemic preconditioning
or control groups in a 1:1 ratio using manually shuffled blocks of 10,
generated by the study coordinator. The allocation sequence was
concealed until study groups were assigned. The study coordinator
opened the opaque, sealed envelope containing the patient’s group
assignment before the patient arriving at the operating room.
For patients randomized to remote ischemic preconditioning,
a tourniquet cuff (Stryker, Kalamazoo, MI) was placed on one thigh
after the induction of anesthesia. The cuff was inflated 3 times to a
pressure of 200mmHg for 5min with 5-min intervals of reperfusion
between inflations. The remote ischemic preconditioning regimen
was conducted while patient monitors, intravascular catheters, and
an indwelling bladder catheter were being placed in order not to
affect the time from induction of anesthesia to initial incision
compared with the control group. Tourniquet cuffs were not applied
on control patients. All patients otherwise received standard
intraoperative and perioperative care as directed by the cardiac
surgery and cardiac anesthesiology staff, and all received isoflurane
as part of the anesthetic.
Plasma samples for NGAL, a proposed biomarker for acute
kidney injury, were drawn immediately before the remote ischemic
preconditioning regimen and again 3 h after cardiopulmonary
bypass. Serum samples for creatinine were drawn o24 h before
surgery and again within the first and second postoperative 24-h
periods. The concentration of NGAL was measured by fluorescence-
based immunoassay (Triage NGAL, Biosite, San Diego, CA), and
levels of serum creatinine were measured by enzymatic colorimetric
assay (Cobas 6000, Roche, Basel, Switzerland). Patients were blinded
to group assignment, as were people performing creatinine and
NGAL assays.
Trial outcomes
The primary outcome was acute kidney injury, defined as any post-
operative increase in the serum creatinine level ofX0.3mg/dl above
the preoperative value, or X50% increase from the preoperative
Kidney International (2011) 80, 861–867 865
RF Zimmerman et al.: Preconditioning prevents AKI o r ig ina l a r t i c l e
value, occurring within 48 h after surgery (that is, creatinine-based
criterion of AKIN). Secondary outcomes were oliguria, defined as
urine output o0.5ml/kg/h for 46 h during the initial 12 h after
surgery and change in plasma NGAL levels from baseline to 3 h after
cardiopulmonary bypass.
In post hoc analysis we assessed acute kidney injury sustained for
X2 and X3 consecutive days. For this purpose, serum creatinine
had to be X0.3mg/dl above the preoperative value on each of the
consecutive days. We retrospectively collected serum creatinine
data through postoperative day 5 when available from the clinical
laboratory. Whereas there were insufficient data to analyze acute
kidney injury with onset 448 h after surgery, among patients with
acute kidney injury occurring within 48 h of surgery there were
continuous data through postoperative days 3 and 4 for 89% and
79% of control patients and 83% and 67% of preconditioned
patients, respectively (see Supplementary Tables S1 and S2 online).
We assessed acute kidney injury, according to AKIN stages I–III,
occurring within the first postoperative 48 h and using creatinine
criteria only; that is, oliguria was not considered. AKIN stage I
represents an increase in serum creatinineX0.3mg/dl or an increase
to 150% up to 200% of baseline; stage II, an increase to above 200%
up to 300% of baseline; stage III, an increase to above 300% of
baseline. We also assessed differences in the need for continuous or
intermittent renal replacement therapy during the index hospitaliza-
tion, the use of inotropic or vasopressor drugs at any time within
48 h after surgery and at 48 h, the need for mechanical ventilation
for 448 h, reintubation, postoperative myocardial infarction or
congestive heart failure, intensive care unit stay for43 days, length
of hospital stay after surgery, and death in the hospital.
Data collection
Baseline demographic and clinical data were obtained from hospital
clinical records. We recorded the following comorbidities: history of
diabetes mellitus, recent use of insulin before admission, history of
hypertension, peripheral vascular disease, congestive heart failure,
and chronic obstructive pulmonary disease. We also recorded
history of previous cardiac surgery, date of most recent cardiac
catheterization, left ventricular ejection fraction obtained by
echocardiography or contrast ventriculography, and use of an
intraaortic balloon pump o2 weeks before surgery.
For each patient, we calculated a propensity score (scale of 0 to
17 points) based on gender, congestive heart failure, ejection
fraction, preoperative intraaortic balloon pump, chronic obstructive
pulmonary disease, insulin-requiring diabetes, previous cardiac
surgery, type of surgery, and preoperative creatinine. The propensity
score has been validated for predicting acute kidney injury requiring
renal replacement therapy after cardiac surgery.43
We recorded any use of angiotensin-converting enzyme inhibi-
tors, angiotensin-receptor blockers, nonsteroidal anti-inflammatory
drugs (including cyclooxygenase 2 inhibitors), and sulfonyl-
ureas during the 48 h before surgery. Hourly urine output was
recorded for the first 12 h after surgery, but recording beyond this
point was not feasible because the indwelling urinary catheters of
most patients were discontinued within the first 2 postoperative
days. Type of surgery, cardiopulmonary bypass time, aortic cross-
clamp time, and types of inhaled anesthetics were obtained from
the operative report, anesthesia record, and cardiopulmonary
bypass record. Postoperative interventions, complications, and
length of intensive care unit stay were obtained from a database
maintained by the Cardiac Surgery Division of Maine Medical
Center.
Statistical analysis
We compared baseline data and differences in outcomes between
groups using the w2 test with Yates’ correction for continuity (or
Fisher’s exact test when the expected value was o5) for categorical
variables. Because acute kidney injury propensity scores, changes in
plasma NGAL, and lengths of hospital stay were not normally
distributed based on the w2 goodness-of-fit test, the Mann–Whitney
U test was used for their comparisons between the two treatment
groups. All other differences between groups were assessed using the
unpaired t-test. We did not impute missing data.
For the primary analysis, we analyzed all end points on an
intention-to-treat basis, and we conducted a per-protocol analysis of
all renal outcomes. All reported P-values are two sided and unadjusted
for multiple comparisons. Statistical testing was performed with SAS
software, versions 9.1.3 and 9.2 (SAS Institute, Cary, NC) and
GraphPad QuickCalcs (GraphPad Software, La Jolla, CA). Outcomes
assessors were not blinded to group assignment. Because of an
imbalance in baseline characteristics despite randomization, we
performed post hoc analysis of the primary outcome using a
Mantel–Haenzel w2 test stratified for previous cardiac surgery.
An interim analysis of this study was presented at the annual
meeting of the American Society of Nephrology in October 2009.44 We
did not employ an a-spending function because we would not terminate
the study or publish results, regardless of statistical significance, until full
enrollment of 120 patients as planned.
A review of 100 consecutive patients who underwent cardiac
surgery with cardiopulmonary bypass at Maine Medical Center in
April and May 2008 revealed that 42% met the primary end point of
the currently reported study. We therefore estimated that enrollment
of 120 subjects would provide statistical power of 62% for detecting
a 50% reduction of the primary end point.
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